Your guide to Pharmacy Law and Ethics
Understand the legal and professional obligations of pharmacists and pharmacy technicians in delivering safe, ethical practice.
Monitored dosage systems (MDS), also referred to as multi-compartment compliance aids (MCAs), are used to support some patients in managing their medicines. However, their use is not required by law and must be considered within the framework of professional judgement, medicines legislation, and patient safety.
There is no legal requirement for pharmacies to provide medicines in an MDS.
The decision to supply medicines in this format is governed by:
Medical devices are regulated separately from medicines and are subject to a distinct legal framework in the UK. It is important to understand what qualifies as a medical device, how devices are classified, and the regulatory requirements that apply to their supply and use.
Under the Medical Devices Regulations 2002 (SI 2002/618) (as amended), a medical device is:
👉 Key legal distinction:
A medical device does not achieve its principal intended action by pharmacological, immunological, or metabolic means, although such means may assist its function.
Pharmacists may be asked to supply or hand over medicines to a child or young person, either:
There is no absolute legal prohibition on a child collecting medicines. However, the decision to supply must be made using professional judgement, taking into account medicines legislation and regulatory standards.
Under the Human Medicines Regulations 2012, medicines may be supplied to a patient or their representative.
The donation of medicines, particularly internationally, is subject to strict legal and regulatory controls in the UK. While often well-intentioned, inappropriate donation can breach medicines legislation and create risks for both the donor and recipient.
Pharmacists and pharmacy owners must ensure that any donation complies with UK medicines law, wholesale distribution requirements, and recognised international guidance.
Under the Human Medicines Regulations 2012, supplying a medicine to another organisation for onward supply is considered wholesale dealing.
Homeopathic and herbal medicines are distinct categories of products with different legal frameworks, regulatory requirements, and evidential standards. It is important to distinguish between them in order to apply the correct legal and professional approach.
Homeopathic products:
Herbal products:
Child-resistant containers (CRCs) are a key safety measure designed to reduce the risk of accidental poisoning in children. In community pharmacy practice, there is a strong expectation that medicines are supplied in suitable child-resistant packaging unless there is a valid reason not to do so.
Under UK law, the requirement for child-resistant packaging primarily arises from:
These regulations require that certain medicines are supplied in child-resistant containers where appropriate, particularly where there is a risk of harm if ingested by a child.
Secure environments include prisons, police custody suites, secure hospitals, immigration removal centres, and other places where individuals are detained. These settings present unique legal and operational considerations because they sit at the intersection of healthcare law, custodial law, and medicines legislation.
UK medicines legislation (e.g. the Human Medicines Regulations 2012) does not always explicitly refer to these environments. In practice, pharmacy services must apply principles from primary care or secondary care, depending on the context, while remaining within the relevant legal framework.
Where medicines are dispensed from an in-house prison pharmacy for administration or supply to patients within the same prison:
Amendments to the Poisons Act 1972 and subsequent regulations have changed how poisons and certain chemicals are classified and regulated in the United Kingdom.
Pharmacies that supply regulated poisons or certain chemicals must comply with legal requirements relating to licensing, record keeping, and reporting suspicious activity.
The main legislation governing the sale and supply of poisons is the Poisons Act 1972 and the Poisons Regulations 2015.
In the UK, a medicinal product may only be sold or supplied in accordance with its marketing authorisation.
The marketing authorisation (also referred to as the product licence) sets out the legally binding conditions under which a medicine may be marketed, sold and supplied.
Compliance with a product’s marketing authorisation is a legal requirement under the Human Medicines Regulations 2012.
Pseudoephedrine and ephedrine are active ingredients found in certain pharmacy (P) medicines, commonly used as decongestants.
Due to their potential use in the illicit manufacture of methylamphetamine (a Class A controlled drug), the sale and supply of pseudoephedrine- and ephedrine-containing medicines are subject to specific statutory restrictions under the Human Medicines Regulations 2012.
These restrictions apply in addition to the general legal requirements for pharmacy medicines.